JAMES M MARTIN
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology CLEVELAND, OH NPI 1558708693
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology OH PFIZER INC. All categories
General Payments — all program years on this page
$53,590.16
- Category: General Payments
- Program years: PY2018–2024
- Record count: 66
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $20,002.43 across 28 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $18,200.00 | 4 |
| Food and Beverage | $1,165.50 | 21 |
| Travel and Lodging | $537.93 | 2 |
| Education | $99.00 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $19,253.88 | 13 |
| Amgen Inc. | $265.58 | 2 |
| BeiGene USA, Inc. | $139.17 | 1 |
| Incyte Corporation | $127.59 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $32.41 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $30.57 | 1 |
| Daiichi Sankyo Inc. | $25.48 | 1 |
| Lilly USA, LLC | $24.84 | 1 |
| EISAI INC. | $22.37 | 1 |
| GlaxoSmithKline, LLC. | $19.81 | 1 |
| Genentech USA, Inc. | $18.31 | 1 |
| Acerta Pharma LLC | $14.74 | 1 |
| Rigel Pharmaceuticals, Inc. | $13.89 | 1 |
| SpringWorks Therapeutics, Inc. | $13.79 | 1 |
By program year
Records — PY2024 (28)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.